Population-based case-control study of oxoline acid use during pregnancy for birth outcomes

Congenital Anomalies

Volumn 46, Issue 1, 2006, Pages 39-42

  Dudás, István ^a   Puhó, Erzsébet ^a   Czeizel, Andrew E ^a  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Case control analysis; Congenital abnormalities; Human teratogenic potential; Oxoline acid; Preterm birth

Indexed keywords

BACTERICIDE; DROTAVERINE; NALIDIXIC ACID; NITROFURANTOIN; OXOLINE ACID; OXOLINIC ACID; PENAMECILLIN; PROMETHAZINE; TERBUTALINE; UNCLASSIFIED DRUG; URINARY TRACT ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BIRTH WEIGHT; CHEMICAL TERATOGENESIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG HALF LIFE; FEMALE; FETOTOXICITY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; POPULATION BASED CASE CONTROL STUDY; PREGNANCY OUTCOME; PRIORITY JOURNAL; TERATOGENICITY; URINARY TRACT INFECTION; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; FETOMATERNAL TRANSFUSION; HEALTH SURVEY; PREGNANCY; PREMATURITY; PROSPECTIVE STUDY;

ABNORMALITIES, DRUG-INDUCED; ANTI-INFECTIVE AGENTS, URINARY; BIRTH WEIGHT; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; OXOLINIC ACID; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PROSPECTIVE STUDIES;

EID: 33646824683     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/j.1741-4520.2006.00100.x     Document Type: Article

References (14)

1. Andriole VT (1980) The Quinolones. Academic Press, London.
2. Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in Pregnancy and Lactation, 5th edn. Williams & Wilkins, Baltimore.
3. Czeizel AE (1997) The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 55: 299-305.
4. Czeizel AE, Puhó E (2004) A possible association between congenital abnormalities and the use of different sulfonamides during pregnancy. Congenit Anom Kyoto 44: 79-86.
5. Czeizel AE, Rockenbauer M (2001) The ethical issues of the postmarketing surveillance of drug teratogenicity in Hungary. Pharmacoepidemiol Drug Saf 10: 638-639.
6. Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J (2001a) Risk of infantile pyloric stenosis in infants exposed to nalidixic acid: A population-based case-control study. Int J Gynecol Obstet 73: 221-228.
7. Czeizel AE, Rockenbauer M, Siffel Cs Varga E (2001b) Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 63: 176-185.
8. Czeizel AE, Petik D, Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 12: 409-416.
9. Food and Drug Administration (FDA) (1980) Fetal Risk Categories. Federal Register 40: 74434-74467.
10. Friedman JM, Polifka JE (1996) The Effects of Drugs and Nursing Infants. The Johns Hopkins University Press, Baltimore.
11. Hooper DC (1995) Quinolones. In: Hooper DC (ed). Principles and Practices of Infectious Diseases. Churchill Livingstone, New York, pp. 364-376.
12. Irikura T, Imado O, Suzuki H, Abe Y (1981a) Teratological study of 1-ethyl-6-fluors-1, 4-dihydro-4-oxo-7-(1-piperazinyl) -3-quinolizecarboxilic acid (AM-715). Kiso Rivsho 15: 5251-5263.
13. Irikura T, Suzuki H, Sugimoto T (1981b) Reproductive studies of AM-175. Chemotherapy 29: 886-894, 895-914, 915-931.
14. Shepard TH, Lemire RJ (2004) Catalog of Teratogenic Agents, 11th edn. Johns Hopkins University Press, Baltimore.